[Form 4] PHIBRO ANIMAL HEALTH CORP Insider Trading Activity
Rhea-AI Filing Summary
Phibro Animal Health insider activity shows trades by BFI Co., LLC, an entity associated with President and CEO Jack Bendheim and a 10% owner. On February 4, 2026, BFI converted 30,000 shares of Class B Common Stock into Class A on a one-for-one basis at $0 per share.
BFI then sold Class A shares in several transactions: 6,689 shares at $41.2508, 2,971 shares at $41.9667, and 3,520 shares at $41.1544, all reported as weighted average prices under a Rule 10b5-1 trading plan adopted on May 30, 2025. After these trades, BFI held 48,800 Class A shares indirectly, while Bendheim directly held 16,840 Class A shares and BFI continued to hold additional Class B shares. Bendheim may be deemed to share voting and investment power over BFI’s holdings but disclaims beneficial ownership except for his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Class B Common Stock | 30,000 | $0.00 | -- |
| Conversion | Class A Common Stock | 30,000 | $0.00 | -- |
| Sale | Class A Common Stock | 3,520 | $41.1544 | $145K |
| Sale | Class A Common Stock | 6,689 | $41.2508 | $276K |
| Sale | Class A Common Stock | 2,971 | $41.9667 | $125K |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC ("BFI") on May 30, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.69 to $41.68. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 and 6. The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.70 to $42.62. Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, at the holder's election, and has no expiration date. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.535 to $41.52. The reported securities are directly held by Jack Bendheim.
